A Better Diabetes Drug - SciTechDaily

A new type of 2 diabetes drug reduced the chance of heart failure hospitalization. Sodium-glucose co-transporter 2 inhibitors (SGLT-2i) have shown therapeutic potential in cardiovascular outcome studies among individuals with type 2 diabetes (T2D), including …

SGLT-2i patients had a comparable risk of myocardial infarction, stroke, and all-cause death, but a decreased risk of heart failure hospitalization compared to patients taking metformin. A new type … [+2116 chars]

full article...